Introduction
============

Osteoporosis is a disease in which bones become fragile, leading to increased bone fracture risk. At present, 200 million people are estimated to suffer from osteoporosis worldwide ([@B4]). Although the pathogenesis of osteoporosis is still not fully understood, recent findings support that reactive oxygen species (ROS) are important in the development of osteoporosis ([@B3]; [@B16]; [@B29]). High levels of lipid peroxidation, along with low activities of antioxidant enzymes, were reported in the blood of postmenopausal osteoporotic women and in the femora of ovariectomized rats ([@B28]; [@B31]).

In all cases of osteoporosis, there is an imbalance between bone resorption and bone formation. In bones, osteoblasts are responsible for bone formation and osteoclasts are associated with bone degradation. Osteoporosis can occur when bone formation decreases and bone resorption increases or remains unchanged, leading to a net bone loss ([@B16]). ROS accelerate apoptosis of osteoblasts, inhibit their differentiation, and impair bone formation ([@B1]; [@B36]; [@B21]).

Danshensu \[β-(3, 4-dihydroxyphenyl)lactic acid\] is a prominent water-soluble compound extracted from Radix *Salviae miltiorrhizae* (known as 'Danshen' in Chinese). It has been widely used in clinics in China for the treatment of various microcirculatory disturbance-related diseases ([@B50]). DSS reduces inflammation and suppresses ROS formation ([@B20]; [@B26]; [@B17]). Apart from these effects, DSS also produces beneficial effects on bone formation. For example, previous studies revealed that DSS not only stimulated osteoblast differentiation and bone matrix formation, but also oriented rMSCs to osteogenesis ([@B6]; [@B14]).

Hydrogen sulfide (H~2~S), an endogenous gaseous mediator, is produced by pyridoxal-5′-phosphate-dependent enzymes, including cystathionine γ-lyase (CSE), CBS and 3-MST during the cysteine metabolism ([@B15]; [@B25]). Along with nitric oxide (NO) and carbon monoxide (CO), H~2~S plays multiple physiological and pathological functions in various biological systems ([@B15]; [@B25]). It exerts protective effects against various stimuli-triggered injuries. For example, H~2~S protects neurons against neurotoxins-induced brain injury ([@B40]; [@B27]). H~2~S also decreases the mortality of myocardial cells during ischemia-reperfusion injury or metabolic inhibition ([@B32], [@B33]; [@B38]; [@B47],[@B48]). A recent study from our laboratory revealed that H~2~S protects osteoblastic cells from H~2~O~2~-induced cell injury ([@B45]). All the aforementioned biological effects are related to the antioxidant effects of H~2~S.

On the basis of these findings, we synthesized SDSS (**Figure [1A](#F1){ref-type="fig"}**), a hybrid compound derived from Ac-DSS and ADT-OH (a proven H~2~S-releasing moiety). We hypothesized that H~2~S-releasing SDSS molecule may protect osteoblasts from oxidant-stress-induced cell injury and stimulate cell differentiation.

![**Characterization of the new H~2~S releasing compound SDSS. (A)** Structural formulas of DSS and SDSS. SDSS is a hybrid of Ac-DSS and ADT-OH. **(B)** HPLC chromatograms of SDSS. Rats were administered with 30 mg/kg ADT-OH (a-c) or SDSS (e--g). Chromatograms were recorded at 330 nm by analyzing plasma 5, 15, and 30 min after injection. For the bottom panels (d and h), samples from ADT-OH (d) and SDSS (h) groups were spiked with additional solution of ADT-OH in ACN (with the arrow) and immediately analyzed by HPLC. The final concentrations of spiking ADT-OH in sample ADT-OH and SDSS were 0.01 mM and 0.02 mM, respectively. **(C)** Proposed diagram of metabolic degradation of SDSS and the release of H~2~S. The metabolic degradation of AFT-OH was proposed by [@B11]. **(D)** Detection of intracellular H~2~S released from SDSS in MC3T3-E1 cells. Cells were pretreated with probe 8 (20 μM) in DOTAP liposome for 2 h, and then treated with SDSS or Na~2~S for 3 h. Representative fluorescent images were taken using a confocal microscopy. Ex = 633 nm, Em above 650 nm. Magnification: ×200. Both Na~2~S and SDSS significantly increased the fluorescence intensity.](fphar-08-00007-g001){#F1}

Materials and Methods {#s1}
=====================

Chemicals and Reagents
----------------------

DSS was purchased from Baoji Herbest Bio-Tech Co., Ltd (Baoji, Shanxi, China). Other chemicals: NaHS, Na~2~S (for probe detect H~2~S, we use Na~2~S as H~2~S donor), methylthiazolyltetrazolium (MTT), Hoechst 33342, LY294002, 2′, 7′ -- H~2~DCFDA and Glutathione Assay Kit were purchased from Sigma--Aldrich (St. Louis, MO, USA). Primary antibodies against phosphorylated extracellular- signal-regulated kinase 1/2 (ERK1/2), phosphorylated p38, phosphorylated c-Jun N-terminal kinase (JNK), phosphorylated Akt, and total ERK1/2, p38, JNK and Akt were purchased from Cell Signaling Technology (Beverly, MA, USA). The superoxide dismutase (SOD) assay kit was purchased from Cayman Chemical (Ann Arbor, MI, USA). The iScriptTM complementary DNA (cDNA) synthesis kit was purchased from Bio-Rad Laboratories (Singapore).

Experimental Animals
--------------------

Adult Sprague Dawley rats (180--220 g) and new born Sprague Dawley rats were used for evaluation of SDSS metabolism in plasma and primary osteoblast culture respectively. Both protocols were approved by Institutional Animal Care and Use Committee of Xi'an Jiaotong University.

Synthesis of SDSS
-----------------

The chemical structure of SDSS is shown in **Figure [1A](#F1){ref-type="fig"}**. The steps involved in SDSS synthesis was as follow:

1.  Synthesis of ADT-OH: ADT-OH was prepared according to [@B22]. Briefly, Anethole (80 mmol) was mixed with sulfur (560 mmol) in 40 ml of dimethylacetamide and heated at 145°C for 6 h. After incubation overnight at room temperature, unreacted sulfur was filtered and the solution was diluted with water (400 ml) to precipitate anethole dithiolethione sulphoraphane (ADT). The product was washed with ether and recrystallized from ethyl acetate to obtain ADT as dark orange needle-shaped crystals (13.789 g, 72%). ADT (3 g) and pyridine hydrochloride (15 g) was then mixed and heated at 215°C under N~2~ for 25 min. After cooling, HCl (1 M) in excess was added to the solution, and the precipitate was filtered and washed with water. After drying, the residue was purified by silica gel column chromatography (CH~2~Cl~2~ as eluant) to give ADT-OH (1.418 g, 50%). The maximal absorbance peak of ADT-OH was at 349 nm. ^1^H NMR: δ 7.59 (d, *J* = 9.0 Hz, 2H), 7.39 (s, 1H), 6.93 (d, *J* = 9.0 Hz, 2H). Electrospray ionization mas spectrometry: *m/z* calcd for \[M-H\]^-^ C~9~H~5~S~3~O, 225.0, found 225.1.

2.  Synthesis of Ac-DSS: DSS (2.0 g, 10 mmol) was added to a mixed solution of acetic anhydride (16 ml) and pyridine (1 ml), and the resulting mixture was stirred overnight at room temperature. The reaction mixture was poured into ice-water and acidized with 1M HCl to pH 2. The product was extracted with ethyl acetate three times, and the combined organic layers were washed with water and brine, and then finally dried over Na~2~SO~4~. The organic solvent was evaporated under reduced pressure, and the yellow oil residue was purfied by column chromatography on silica gel and eluted with CH~2~Cl~2~/CH~3~OH (v/v, 98:2) to give a white waxy Ac-DSS (1.688 g, 52%). ^1^H NMR: δ 7.13 -7.09 (m, 3H), 5.23-5.19 (dd, *J* = 9.0, 6.0 Hz, 1H), 3.24-3.18 (dd, *J* = 15.0, 6.0 Hz, 1H), 3.14--3.07 (dd, *J* = 15.0, 9.0 Hz, 1H), 2.28 (s, 6H), 2.10 (s, 3H). Electrospray ionization mas spectrometry: *m/z* calcd for \[M-H\]^-^ C~15~H~15~O~8~, 323.1, found 322.9.

3.  Synthesis of SDSS: A solution of dicyclohexylcarbodiimide (2.57 mmol) in anhydrous dichloromethane (5 ml) was added dropwise to a solution containing Ac-DSS (2.58 mmol), ADT-OH (2.15 mmol), and 4-dimethylaminopyridine (0.39 mmol) in dichloromethane (15 ml) at 0°C under N~2~. The mixture was stirred for 1.5 h at room temperature. After the white dicyclohexylurea had been filtered, the filtrate was washed with 1 M HCl (20 ml), H~2~O (20 ml) and NaHCO~3~ (aqueous saturated, 20 ml) and brine consecutively. The organic solution was evaporated under reduced pressure, and the residue was purified by reversed-phase chromatography (RP-18, H~2~O/ACN, v/v, 60:40--50:50) to give SDSS (851 mg, 71%) as an orange solid ([@B39]). The maximal absorbance peak of SDSS was at 318 nm. ^1^H NMR: δ 7.64 (d, *J* = 9.0 Hz, 2H), 7.39 (s, 1H), 7.19-7.15 (m, 3H), 7.04 (d, *J* = 9.0 Hz, 2H), 5.36 (t, *J* = 6.0 Hz, 1H), 3.28 (d, *J* = 6.0 Hz, 2H), 2.31 (s, 3H), 2.30 (s, 3H), 2.18 (s, 3H). Electrospray ionization mas spectrometry: *m/z* calcd for \[M+H\]^+^ C~24~H~21~S~3~O~8~, 533.0, found 533.0.

^1^H NMR spectra were recorded with an AC300 spectrometer (Bruker, Karlsruhe, Germany) at 300 MHz, using CDCl~3~ as solvent. The electrospray ionization mass spectra were obtained with an LCQ ion trap mass spectrometer (Finnigan MAT, San Jose, CA, USA) in negative electrospray ionization mode. Atmospheric pressure chemical ionization mass spectra were collected with a Brucker amaZonX mass spectrometer.

HPLC Analyses of Drugs Metabolites
----------------------------------

Metabolites of ADT-OH and SDSS *in vivo* experiments were detected by a Waters HPLC system (Milford, MA, USA) with an Alliance 2659 separation module, a 2996 photodiode array (PDA) detector ([@B12]). Briefly, Sprague-Dawely rats were anesthetized with Ketamine/xylazine (75/10 mg/kg) mixture. SDSS or ADT-OH (30 mg/kg) was injected in the lateral tail vein ([@B49]). Blood samples were collected through cardiac puncture 5, 15, and 30 min after injection. 20 μl of plasma were added to 60 μl of HPLC grade ACN and vigorously shaken for 30 s. After centrifugation, 50 μl supernatant were added with 5 μl of 1% (v/v) TFA. The resulting samples were load onto an HPLC column apparatus (Waters C18 column, 4.6 mm × 250 mm, 5 μm, Atlantis, Ireland) and separated by applying a mixture of a 0.05% (v/v) TFA/H~2~O (phase A) and ACN (phase B), gradient: 0--30 min, 64% ACN; 30--45 min, 90% ACN; 45--50 min, 90% ACN; 50--65 min, 64% ACN; 65--85 min, 64% ACN. The flow rate was 6.3 ml/min and the injection volume was 20 μl. The identity of ADT-OH was determined by analyzing plasma samples, spiked with additional solutions of ADT-OH in ACN. The UV detector was recorded at 330 nm.

SDSS-Releasing H~2~S Assay
--------------------------

To image the release of H~2~S from SDSS, a highly selective and sensitive H~2~S probe 8 was used ([@B42]). Briefly, MC3T3-E1 cells were seeded on a four-well glass chamber slide (Lab-Tek chambered no. 1.0 borosilicate coverglass system) and incubated at 37°C in 5% CO~2~ for 24 h. The cell culture medium was then discarded, and 0.7 ml working medium containing the probe 8 was added. After 2 h incubation, cells were washed with phosphate-buffered saline (PBS) three times to remove the excess probe, and then treated with SDSS or Na~2~S for 3 h. Fluorescence images were taken with a confocal microscopy (Olympus IX 81, Fluroview FV1000). The H~2~S probe 8 was excited at 633 nm, and the emission above 650 nm was collected.

Cell Culture and Treatment
--------------------------

The murine calvaria-derived MC3T3-E1 osteoblast-like cell line was purchased from the American Type Culture Collection (Manassas, VA, USA). Cells were cultured at 37°C in a humidified atmosphere of 5% CO~2~ and 95% air with alpha minimum essential medium (α-MEM) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin. This basic medium was replenished every 3 days. For cell differentiation, the cells were transferred into the medium supplemented with [L]{.smallcaps}-ascorbic acid and β-glycerol phosphate at a final concentration of 50 μg/ml and 5 mM respectively ([@B9]). Cells were seeded into 60 mm dishes and incubated until 70% confluence was reached. To detect the protection of SDSS against H~2~O~2~-induced cell injury and the underlying signaling mechanisms, MC3T3-E1 cells were pretreated with SDSS for 60 min, washed twice with PBS, and then subjected to H~2~O~2~.

Primary Culture of Osteoblasts
------------------------------

Primary osteoblasts were isolated from the calvaria of 2- to 4-day-old Sprague Dawley rats. Briefly, calvaria were cut to 1-mm^2^ debris, then sequentially digested for 15 min in 1 × PBS that contained 0.2% type IV collagenase with EDTA to remove fibroblasts and for 45 min in 1 × PBS that contained 0.2% type IV collagenase to collect osteoblasts. Cells were expanded for 5--6 days in alpha minimum essential medium containing 10% FBS and plated at a density of 2.5 × 10^4^ cells per square centimeter.

Cell Viability
--------------

Cell viability was evaluated with the MTT method. Briefly, cells were seeded in 96-well plates at approximately 1 × 10^4^/well and cultured overnight. The cells were pretreated with SDSS for 60 min and then incubated in freshly prepared medium containing 400 μM H~2~O~2~ for 4 h. The medium was removed at the end of treatment, and 200 μl fresh medium containing MTT at 0.5 mg/ml was added. After a further incubation at 37 °C for 4 h, the culture medium containing MTT was aspirated. Dimethyl sulfoxide (150 μl) was then added into each well, and the absorbance at 570 nm was measured using a spectrophotometric plate reader.

Annexin V-Fluorescein Isothiocyanate/Propidium Iodide Double Staining Assay
---------------------------------------------------------------------------

The annexin V--fluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis detection kit was purchased from 7 Sea Biotech (Shanghai, China). Annexin V--FITC/PI double staining assays were performed according to the manufacturer's instructions. Briefly, cells in early and late apoptotic stages were quantified by the annexin V--FITC/PI double staining assay. Treated and untreated cells were harvested with trypsinization and washed twice with PBS. Then cells were resuspended in 500 μl binding buffer, followed by staining with 10 μl annexin V and 5 μl PI in the dark at room temperature for 15 min. The stained cells were examined immediately with a fluorescence-activated cell sorting flow cytometry analyzer with emission filters of wavelength 488--530 nm for green fluorescence of annexin V and 488--630 nm for red fluorescence of PI. At least 10,000 events per sample were acquired to ensure obtaining adequate data.

Measurement of Cell Apoptosis With Hoechst 33342 Staining
---------------------------------------------------------

To visualize nuclear morphology, cells were fixed in 4% paraformaldehyde for 5 min and stained with 2.5 μg/ml Hoechst 33342 DNA dye. Uniformly stained nuclei were scored as healthy, viable cells. Condensed or fragmented nuclei were scored as apoptotic. To obtain unbiased counting, petri dishes were coded, and cells were scored blindly without knowledge of their prior treatment.

Caspase 3 Activity Assay
------------------------

Caspase activities were measured with a caspase activity kit according to the manufacturer's instructions (BioVision, Mountain View, CA, USA). Briefly, after different treatments, cells were washed with cold PBS, resuspended in lysis buffer, and left on ice for 15 min. The lysate was centrifuged at 16,000 *g* at 4 °C for 15 min. Activity of caspase 3 was measured with the use of the substrate peptide Ac-DEVDp-nitroanilide. We qualified the release of *p*-nitroanilide by determining the absorbance with a spectrophotometric plate reader at 405 nm. The fold increase in activity was calculated as the ratio between values obtained from treated samples versus those obtained from untreated controls.

Alkaline Phosphatase Activity Assay and Collagen Content Assay
--------------------------------------------------------------

To measure the alkaline phosphatase (ALP) activity and collagen content, cells were pretreated with SDSS for 60 min and then incubated in freshly prepared medium containing 400 μM H~2~O~2~. Four hours later, H~2~O~2~ was washed out with PBS. Cells were cultured with fresh differentiation medium. After 5 days, the medium was collected for extracellular soluble collagen content assay by a Sircol collagen assay kit (Biocolor, Carrickfergus, UK). The monolayer cells were collected and lysed with cell lysis buffer and centrifuged at 12,000 *g* for 10 min. The supernatant was collected, and ALP activity and protein concentration were determined with an ALP activity assay kit (Cell Biolabs, San Diego, CA, USA) and a bicinchoninic acid protein assay kit (Bio-Rad, Hercules, CA, USA) respectively.

Measurement of Extracellular Matrix Calcium Deposits
----------------------------------------------------

Staining with alizarin red S is used to visualize bone nodule formation and calcium deposition of osteoblasts cultured *in vitro* ([@B18]). Cells were pretreated with SDSS for 60 min and then incubated in freshly prepared medium containing 400 μM H~2~O~2~ for 4 h. Then H~2~O~2~ was washed out with fresh differentiation medium and the cells were cultured for 21 days. At harvest, MC3T3-E1 cells were fixed and stained with alizarin red S. Calcium precipitation was visualized by light microscopy.

ROS Measurement
---------------

H~2~DCFDA was used to detect ROS production as described previously ([@B13]). Briefly, cells were seeded in black 96-well plates or 35-mm dishes and cultured overnight. Cells were treated with SDSS for 60 min and then incubated with H~2~O~2~ (400 μM) for 4 h. The culture medium was discarded and the cells were washed twice with PBS. The culture medium was replaced with phenol-red-free Dulbecco's modified Eagle's medium containing H~2~DCFDA (10 μM) for 30 min. ROS production was measured with a fluorescence microscope (Nikon) or a fluorescence reader (Safire2, Tecan Group) at an excitation wavelength of 490 nm and an emission wavelength of 520 nm.

Superoxide Dismutase (SOD) Activity and Glutathione (GSH) Activity
------------------------------------------------------------------

GSH assays were performed according to the instructions of a glutathione assay kit (Sigma). Briefly, cells were suspended in PBS and centrifuged at 600 *g* to obtain packed cell pellets. Then 3 volumes of the 5% SSA solution were then added to cell pellets. Repeated freeze-thaw cycles were undertaken for thorough cell lysis. After centrifugation at 10,000 *g* for 10 min, 10 μl supernatants were added into individual wells, followed by addition of 150 μl working mixture (glutathione reductase and 5,5-dithiobis(2-nitrobenzoic acid) solution) and incubation for 5 min at room temperature. Then 50 μl NADPH solution was added to initiate the reaction. The GSH content was determined by kinetic measurement with 1-min intervals for 5 min at 412 nm and calculated by comparison with standards.

Superoxide dismutase activity was measured in cells using a Superoxide Dismutase Assay Kit (Cayman Chemicals, Inc, Ann Arbor, MI, USA). Briefly, cells were sonicated in 20 mM *N*-(2-hydroxyethyl)piperazine-*N*-ethanesulfonic acid buffer, pH 7.2, containing 1 mM ethylene glycol bis(2-aminoethyl ether)tetraacetic acid, 210 mM mannitol and 70 mM sucrose, on ice. After centrifugation, the supernatants were collected and 10 μl supernatants were added into individual wells. Reaction was initiated by addition of diluted xanthine oxidase to all wells, and then the plate was incubated on a shaker at room temperature for 20 min. The absorbance was read at 450 nm.

Western Blotting Assay
----------------------

Cells were washed twice with chilled PBS and lysed in radioimmunoprecipitation assay lysis buffer. Protein samples were separated by 12 % sodium dodecyl sulfate--polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (GE Healthcare, Chalfont St Giles, UK). After blocking at room temperature in 10 % milk in 10 mM tris(hydroxymethyl)aminomethane-HCl, 120 mM NaCl, and 0.1 % Tween 20, pH 7.4 (TBST buffer) for 1 h, the membrane was incubated with various primary antibodies (1:1000 dilution) at 4°C overnight. Membranes were then washed three times in TBST buffer, followed by incubation with horseradish peroxidase conjugated anti-rabbit IgG (1:10,000 dilution) at room temperature for 1 h and washed three times in TBST buffer. Membranes were visualized with an enhanced chemiluminescence kit (GE Healthcare). Densitometric quantification was performed with ImageJ. The protein bands were quantified and normalized to the total protein concentration.

Quantitative Reverse Transcription PCR
--------------------------------------

Cells were seeded in six-well plates and cultured for 24 h. After different treatments, cells were collected. Total RNA from each well was isolated separately with an RNeasy Mini kit (Qiagen, Valencia, CA, USA). RNA (1 μg) from each well was reverse transcribed separately into cDNA with an iScript cDNA synthesis kit (Bio-Rad, Hercules, CA, USA). Quantitative reverse transcription PCR (qRT-PCR) was performed with SYBR Green quantitative PCR master mix (Applied Biosystems). All amplifications were normalized by β-actin. Data were analyzed using the comparison Ct(2^-ΔΔCt^) method and expressed as fold change compared to respective control. The primer sequences used for the qRT-PCR assay (5′--3′) were as follows: β-actin forward, TGCGTGACATCAAAGAGAAG; β-actin reverse, GATGCCACAGGATTCCATA; runt-related transcription factor 2 (Runx2) forward, TTCTCCAACCCACGAATG CAC; Runx2 reverse, CAGGTACGTGTGGTAGTGAGT; bone sialoprotein (BSP) forward, GAATCCACATGCCTA TTGC; BSP reverse, AGAACCCACTGACCCATT; osteocalcin forward, GAACAGACTCCGGCGCTA; osteocalcin reverse, AGGGAGGATCAAGTCCCG; osterix forward, TGGCCATGCTGACTGCAGCC; osterix reverse, TGGGT AGGCGTCCCCCATGG; heme oxygenase 1 (HO-1) forward, CCAGGCAGAGAATGCTGAGTTCATG; HO-1 reverse, TGCAGCTCTTCTGGGAAGTAGACAG; glutamate-cysteine ligase modifier subunit (GCLM) forward, CCCAGATTTGGTCAGGGAGTTTCCA; GCLM reverse, ACTGAACAGGCCATGTCAACTGCA.

Luciferase Activity
-------------------

ARE-Luc reporter plasmids were purchased from Yeasen Biotechnology (Shanghai, China). The MC3T3-E1 cells, cultured in a 24-well plate, were transfected with 100 ng pARE-Luc-Neo plasmid and 20 ng pCMV-β-gal by means of the FuGENE 6 protocol (Roche Molecular Biochemicals). The day after transfection, the medium was replaced with fresh medium. Cells were cultured for an additional 12 h before drug treatment. Then the cells were treated with SDSS or DSS. After treatment, cells were washed twice with ice-cold PBS and harvested in reporter lysis buffer. The β-galactosidase activity was determined as described previously ([@B30]). The luciferase activity was determined according to the protocol provided by the manufacturer (Promega, Madison, WI, USA).

Statistical Analysis
--------------------

The data are expressed as the mean ± the standard error of the mean. Comparison of multiple groups was performed by one-way analysis of variance followed by Tukey's *post hoc* test. A probability level of less than 0.05 was used to establish significance.

Results
=======

SDSS Metabolism in Rat Plasma
-----------------------------

The levels and formation of metabolites of SDSS were evaluated in rat plasma 5--30 min after administration of the SDSS (30 mg/kg) or ADT-OH (30 mg/kg). As shown in **Figure [1B](#F1){ref-type="fig"}**, SDSS was rapidly deacetylated, yielding deacetylated metabolite which, in turn, was hydrolyzed to produce dithiolethione moiety (ADT-OH) and DSS. SDSS was also de-esterificated and generated concomitantly ADT-OH and Ac-DSS. Moreover, the metabolism of the deacetylation and de-esterification products was completed within 5 min as evidenced by the rapid disappearance of these products accompanied by the appearance of ADT-OH and its metabolites. The retention time of ADT-OH was at 10.7 min. This was proved by plasma samples spiked with additional solution of ADT-OH and the peak area was evidently enhanced (**Figure [1B](#F1){ref-type="fig"}**). The retention time of metabolites 1 and 2 was 5.1 min and 6.6 min, respectively. Peaks 1 and 2 are the metabolites of ADT-OH, (a, b, or c) shown in **Figure [1C](#F1){ref-type="fig"}**. The retention time of the final metabolite at 6.6 min reached the maximal level at 15 min after the administration of SDSS and decreased relatively slower over time. The last metabolic degradation of SDSS \[**Figures [1B](#F1){ref-type="fig"}**(e--g)\] was similar to that of ADT-OH \[**Figures [1B](#F1){ref-type="fig"}** (a--c)\]. The release of SDSS was further proved by plasma samples spiked with additional solution of ADT-OH and the peak area was evidently enhanced \[**Figures [1B](#F1){ref-type="fig"}**(d,h)\]. According to the previous reports, ADT-OH was found to release H~2~S at different periods from the three sulfur atoms of the trithione moiety ([@B39]; [@B11]). We therefore speculate that SDSS containing a dithiolethione moiety also releases H~2~S (**Figure [1C](#F1){ref-type="fig"}**).

SDSS Releases H~2~S in MC3T3-E1 Cells
-------------------------------------

We further detected H~2~S released from SDSS with a fluorescent probe 8, a highly selective and sensitive H~2~S probe which takes advantage of Cu(II)-cyclen complex as the quencher of fluorescence and the reaction center for H~2~S; once reacted with H~2~S, it can fluoresce up to 20 folds more. As shown in **Figure [1D](#F1){ref-type="fig"}**, after treatment with 100 μM inorganic H~2~S donor Na~2~S, the MC3T3-E1 cells showed large fluorescent signals compared to that of control cells, which indicates probe 8 can detect H~2~S well in MC3T3-E1 cells. SDSS at both 50 and 100 μM also significantly increased the fluorescence intensities in cells, confirming that SDSS released H~2~S in MC3T3-E1 cells.

SDSS Alleviates H~2~O~2~-Induced MC3T3-E1 Cell Injury
-----------------------------------------------------

Treatment with SDSS at a concentration range from 1 to 100 μM for 30 h did not significantly affect MC3T3-E1 cell viability (**Figure [2A](#F2){ref-type="fig"}**). Interestingly, SDSS at 25 μM or higher produced significant protective effects against H~2~O~2~-induced cell injury (**Figure [2B](#F2){ref-type="fig"}**). Both DSS and NaHS at 25 μM did not produce significant beneficial effects (**Figure [2C](#F2){ref-type="fig"}**). At 100 μM, NaHS produced a comparable protective effect compared with that caused by SDSS at 25 μM. The protective effect of SDSS was further confirmed with the primary cultured rat osteoblasts. Pretreatment with 25 μM SDSS reversed the decreased cell viability from 57.6% in H~2~O~2~ treatment group to 91.7% (**Figure [2D](#F2){ref-type="fig"}**).

![**Effects of SDSS on H~2~O~2~-induced cell injury in MC3T3-E1 osteoblastic cells.** Cell viability was determined by the methylthiazolyltetrazolium assay. **(A)** Effect of SDSS (0--100 μM) alone. **(B)** Concentration-dependent effect of SDSS and DSS against H~2~O~2~-induced cell injury. **(C)** Comparison of the effect of DSS, SDSS, and NaHS on H~2~O~2~-treated cells (400 μM, 4 h). **(D)** Effect of SDSS on viability of primary cultured rat osteoblasts in cells treated with H~2~O~2~ for 4 h. Mean ± standard error of the mean, *n* = 4--8. ^∗^*p* \< 0.05 versus the control groups (c); \#*p* \< 0.05 versus the H~2~O~2~ groups; veh, vehicle.](fphar-08-00007-g002){#F2}

SDSS Inhibits H~2~O~2~-Induced Apoptosis in MC3T3-E1 Cells
----------------------------------------------------------

Both Annexin V-FITC/PI double staining (**Figure [3A](#F3){ref-type="fig"}**) and Hoechst 33342 staining assays (**Figure [3B](#F3){ref-type="fig"}**) were performed to quantify the apoptosis of MC3T3-E1 cells. As presented in **Figures [3A,B](#F3){ref-type="fig"}**, H~2~O~2~ triggered a higher magnitude of apoptosis relative to the control. After treatment with SDSS (25 μM), the percentage of apoptotic cells dropped significantly. This was not observed in cells treated with DSS (25 μM). Cytochrome c release is an obvious phenomenon in the early period of apoptosis. Western blotting analysis also showed that H~2~O~2~ induced cytochrome c release and SDSS inhibited this effect (**Figure [3C](#F3){ref-type="fig"}**). In addition, SDSS also decreased the H~2~O~2~-stimulated caspase 3 activity (**Figure [3D](#F3){ref-type="fig"}**). These results suggest that SDSS, but not DSS, produced a significant antiapoptotic effect.

![**Effect of SDSS on H~2~O~2~-induced cell apoptosis. (A)** Cell apoptosis was detected by annexin V--fluorescein isothiocyanate/propidium iodide double staining and examined with a fluorescence-activated cell sorting flow cytometry analyzer. **(B)** Cell apoptosis was detected by Hoechst 33342 staining in cells treated with vehicle, H~2~O~2~, H~2~O~2~+ DSS (25 μM) and H~2~O~2~ + SDSS (25 μM). Cells with condensed or fragmented nuclei were identified as apoptosis cells and counted based on nuclear condensation or fragmentation. **(C)** Representative Western blots and group data for cytochrome c cytosolic expression. Pretreatment with SDSS (25 μM, 1 h) significantly inhibited H~2~O~2~ induced release of cytochrome c. **(D)** Caspase 3 activity in differently treated cells. SDSS reduced the H~2~O~2~-induced increased caspase 3 activity. Mean ± standard error of the mean, *n* = 4--8. ^∗^*p* \< 0.05 versus control (c); \#*p* \< 0.05 versus H~2~O~2~ group; cyto, cytochrome; DSS, danshensu; veh, vehichle.](fphar-08-00007-g003){#F3}

SDSS Stimulates Osteoblast Differentiation under Normal and Oxidant Conditions
------------------------------------------------------------------------------

We first investigated the effects of SDSS and DSS on osteoblast differentiation under normal condition. Both SDSS and DSS (25 μM, 18 h) stimulated BSP, osteocalcin, osterix, and Runx2 mRNA expression (**Figure [4A](#F4){ref-type="fig"}**) and ALP activity (**Figure [4B](#F4){ref-type="fig"}**). This is consistent with the previous reports that DSS can stimulate osteoblast differentiation ([@B6]; [@B14]). Treatment with H~2~O~2~ (400 μM) for 4 h markedly reduced mRNA levels of BSP, osteocalcin, osterix, and Runx2. Pretreatment with SDSS, but not DSS (25 μM, 1 h), reversed these effects (**Figure [4C](#F4){ref-type="fig"}**). ALP activity and collagen expression were largely reduced in both MC3T3-E1 cells (**Figures [4D,E](#F4){ref-type="fig"}**) and primary cultured osteoblasts (**Figure [4F](#F4){ref-type="fig"}**) on the fifth day after the short-term treatment with H~2~O~2~ (400 μM, 4 h). Pretreatment with SDSS but not DSS reversed these effects. Alizarin red S staining showed that pretreatment with SDSS reversed H~2~O~2~-suppressed bone nodule formation (**Figure [4G](#F4){ref-type="fig"}**). These data suggest that SDSS may restore osteoblast differentiation function during oxidative stress.

![**Effect of SDSS on MC3T3-E1 cell differentiation. (A,C)** Quantitative reverse transcription PCR analysis of the messenger RNA (mRNA) levels of bone sialoprotein (BSP), runt-related transcription factor 2 (Runx2), osterix, and osteocalcin in the absence **(A)** or presence **(C)** of H~2~O~2~. **(B,D)** Effect of SDSS and DSS on alkaline phosphatase (ALP) activity in cells treated without **(B)** and with **(D)** H~2~O~2~. **(E)** SDSS but not DSS attenuated H~2~O~2~ down-regulated collagen expression in MC3T3-E1 cells on day 5 after H~2~O~2~ treatment. **(F)** Effect of SDSS and DSS on ALP activity and collagen expression in the primary cultured osteoblasts on day 5 after H~2~O~2~ treatment. **(G)** Representative image of mineralized bone nodule formation. H~2~O~2~ decreased bone nodule formation and SDSS alleviated the effect of H~2~O~2~. Mean ± standard error of the mean, *n* = 4-8. ^∗^*p* \< 0.05 versus control (c); \#*p* \< 0.05 versus H~2~O~2~ group.](fphar-08-00007-g004){#F4}

SDSS Produces Anti-oxidant Effects in MC3T3-E1 Cells
----------------------------------------------------

We further determined the anti-oxidant effect of SDSS. As shown in **Figure [5A](#F5){ref-type="fig"}**, pretreatment with SDSS (25 μM, 60 min) alleviated H~2~O~2~-induced ROS accumulation. We also studied the involvement of GSH and SOD activity. As expected, pretreatment with SDSS but not DSS reversed H~2~O~2~ reduced intracellular GSH concentration and SOD activity (**Figures [5B,C](#F5){ref-type="fig"}**). The ARE-Luc reporter assay showed that SDSS was a potent ARELuc inducer (**Figure [5D](#F5){ref-type="fig"}**). HO-1 and glutamate--cysteine ligase \[comprising a catalytic subunit (GCLC) and a modifier subunit (GCLM)\] are ARE-dependent genes. SDSS (25 μM, 18 h) enhanced HO-1 and GCLM mRNA expression levels (**Figure [5E](#F5){ref-type="fig"}**), but DSS (25 μM, 18 h) failed to produce the similar effects. These results imply that the antioxidant effect of SDSS may not solely come from DSS.

![**Effect of SDSS on the production of reactive oxygen species (ROS) and the activities of antioxidants. (A)** Representative images (left) and group data (right) showing that SDSS, but not DSS, suppressed H~2~O~2~-induced ROS production. **(B,C)** SDSS, but not DSS, reversed H~2~O~2~-reduced GSH **(B)** and SOD **(C)** activity. **(D,E)** SDSS, but not DSS, stimulated antioxidant response element-luciferase activity **(D)** and quantitative reverse transcription PCR analysis of the messenger RNA (mRNA) level of heme oxygenase 1 (HO1) and glutamate-cysteine ligase modifier subunit (GCLM) **(E)**. Mean ± standard error of the mean, *n* = 4--8. ^∗^*p* \< 0.05 versus the control group; \#*p* \< 0.05 versus the H~2~O~2~ group; c, control; DSS, danshensu; Veh, vehicle group.](fphar-08-00007-g005){#F5}

Involvement of MAPKs and the Phosphatidylinositol 3-Kinase (PI3K)/Akt Pathway in the Protective Effect of SDSS
--------------------------------------------------------------------------------------------------------------

We further examined the involvement of MAPKs and PI3K/Akt signaling pathway in the effects of SDSS. As shown in **Figures [6A--C](#F6){ref-type="fig"}**, SDSS pretreatment significantly attenuated H~2~O~2~-induced phosphorylation of ERK1/2, p38, and JNK. These effects were in accordance with the findings of our previous reports that H~2~S protects MC3T3-E1 osteoblasts against H~2~O~2~-induced oxidative damage by inhibition of p38 and ERK1/2 protein kinases. Pretreatment of MC3T3-E1 cells with SDSS alone stimulated Akt phosphorylation in a concentration-dependent manner (**Figure [6D](#F6){ref-type="fig"}**). Inhibition of the PI3K/Akt signaling pathway with LY294002 (15 μM, 15 min; a selective PI3K/Akt inhibitor) reversed the protective effect of SDSS on H~2~O~2~-induced cell injury (**Figure [6E](#F6){ref-type="fig"}**), and abolished the stimulatory effect of SDSS on HO-1 and GCLM mRNA expression (**Figure [6F](#F6){ref-type="fig"}**).

![**Involvement of mitogen-activated protein kinases and the phosphatidylinositol 3-kinase/Akt pathway in the protective effect of SDSS.** Representative Western blots and group data showing the effect of SDSS and DSS on H~2~O~2~-stimulated extracellular signal-regulated kinase 1/2 (Erk1/2; **A**), p38 **(B)**, and c-Jun N-terminal kinase (Jnk; **C**) phosphorylation. **(D)** Representative Western blots and group data showing that SDSS (25 and 100 μM) induced Akt phosphorylation. **(E,F)** LY294002 (15 μM, 15 min) attenuated the effect of SDSS (25 μM, 18 h) on cell viability **(E)**, and messenger RNA (mRNA) expression levels of heme oxygenase 1 (HO-1) and glutamate-cysteine ligase modifier subunit (GCLM) **(F)**. Mean ± standard error of the mean, *n* = 4--6. ^∗^*p* \< 0.05 versus control group; \#*p* \< 0.05 versus the H~2~O~2~ group; +*p* \< 0.05 versus the SDSS group; c, control; DSS, danshensu; Veh, vehicle group.](fphar-08-00007-g006){#F6}

Discussion
==========

The H~2~S-releasing property of SDSS was first examined in this study. SDSS can be rapidly deacetylated or de-esterificated to generate ADT-OH after injection into animals. The retention time of ADT-OH was about 10 min. ADT-OH can release H~2~S from the three sulfur atoms of the trithione moiety ([@B39]; [@B11]). We also further confirmed the release of H~2~S from SDSS in MC3T3-E1 cells by using a novel and sensitive H~2~S probe 8. SDSS increased fluorescence intensities obviously compared with the control group. These results suggest that SDSS is a novel H~2~S-releasing compound and can release H~2~S at a moderate rate.

After confirming the H~2~S releasing property of SDSS, we continued to study the biological functions of SDSS. Both NaHS and DSS have been reported to protect cells against apoptosis and oxidative stress ([@B32]; [@B38]; [@B47]; [@B45]; [@B20]; [@B27], [@B26]). However, the doses of DSS used to study its antioxidant effect are largely varied in different experiments. For instances, [@B26] reported DSS produced significant effect at 1 μM, whereas Cui reported it can only produce a similar protective effect at 300 μM ([@B5]). The discrepancy in DSS concentrations used in different studies is probably due to the different sensitivities of tissues/preparations of the same tissue to DSS. In the present study, we found that DSS alone at 25 μM stimulated osteoblast differentiation in normal situation (without H~2~O~2~ insults), but failed to produce significant beneficial effects in H~2~O~2~-treated MC3T3-E1 cells. These data imply that higher concentration of DSS may be needed to overcome oxidative stress-induced MC3T3-E1 cell injury. Interestingly, even though neither DSS nor NaHS at 25 μM protected osteoblast cells, SDSS at the same concentration produced significant beneficial effects against H~2~O~2~-induced cell injury in MC3T3-E1 cells. Our data imply that the protective effects of SDSS may come from the additive effect from H~2~S and DSS and/or the long-lasting H~2~S- and DSS releasing property.

Oxidative stress not only induced osteoblastic cell apoptosis, but also impeded osteoblasts differentiation ([@B24]; [@B46]). We further investigated the effects of SDSS on MC3T3-E1 cell differentiation. BSP, Runx2, osterix, and osteocalcin are markers representing the osteoblast differentiation phenotype. The mRNA levels of these markers were significantly suppressed in H~2~O~2~-treated MC3T3-E1 cells, and this suppression was reversed by SDSS pretreatment. These data imply that SDSS promotes osteoblast differentiation. We further confirmed this finding by measurement of collagen expression, ALP activity, and bone nodule formation. SDSS also prevented the reduction of ALP activity, the loss of collagen expression, and the inhibition of bone nodule formation in osteoblasts treated with H~2~O~2~. H~2~O~2~ impeded osteoblast differentiation, and SDSS restored the differentiation ability of osteoblasts under oxidant stress.

SDSS exerted protective effects by decreasing H~2~O~2~-induced ROS production. Depletion of GSH and inhibition of SOD activity result in accumulation of ROS and accelerate tissue injury ([@B37]). SDSS stimulated SOD activity and promoted GSH production. Both HO-1 and glutamate-cysteine ligase (including the subunits GCLC and GCLM) are ARE-dependent genes and important factors against oxidant stress ([@B35]). SDSS induced ARE activation. The qRT-PCR results revealed the SDSS effect of increasing HO-1 and GLCM expression. These results partly explained the underlying mechanisms for the SDSS effects on ROS scavenging. Mitochondrial dysfunction is also an important target and source of ROS, and is characterized by an increase in membrane permeability, which caused release of cytochrome c. Mitochondrial dysfunction participates in aging-related disease, including osteoporosis ([@B51]; [@B19]). Our data show that cytosolic cytochrome c accumulation induced by H~2~O~2~ was significantly alleviated after pretreatment with SDSS. These findings indicate that SDSS could overcome oxidative stress and improve mitochondrial function.

Numerous studies have demonstrated that H~2~O~2~-induced apoptosis is mediated by activation of MAPKs ([@B34]). Activated MAPKs participate in cell proliferation, differentiation, and cell death ([@B30]; [@B7]). Our group reported that H~2~S protects osteoblasts from H~2~O~2~-induced cell injury by decreasing activation of H~2~O~2~-induced MAPKs ([@B45]). As SDSS releases H~2~S, we also investigated MAPKs in this study. As expected, SDSS significantly attenuated H~2~O~2~-induced p38, ERK1/2, and JNK phosphorylation. Apoptosis is one of the major outcomes of MAPK activation caused stressors. MAPKs initiate the mitochondrial apoptotic pathway because of enhanced pro-apoptotic protein activation. Previous studies have also reported that activation of p38 MAPK reduces SOD activity in several tissues ([@B2]). SDSS may reverse H~2~O~2~-induced cell injury and decrease SOD activity through inhibition of the MAPKs pathways.

The PI3K/Akt signaling is an important pathway involved in cell differentiation ([@B41]; [@B44]). In osteoporosis model rats, protein expression of phosphorylated PI3K and phosphorylated Akt in bone tissue was decreased dramatically ([@B43]). Akt activation promotes osteogenic differentiation ([@B10]). We therefore examined whether the PI3K/Akt signaling pathway is involved in the protective effects of SDSS. Unlike the MAPK pathway, the PI3K/Akt signaling pathway was significantly activated by SDSS pretreatment. Inhibition of PI3K/Akt pathway attenuated the effects of SDSS on oxidative-stress-induced cell injury and on HO-1 and GCLM mRNA expression. Previous studies have demonstrated that PI3K/Akt signaling plays an important role in expression of antioxidant enzymes, including HO-1, GCLC, and GCLM ([@B8]; [@B23]). SDSS may also reverse H~2~O~2~-impaired GSH content via PI3K/Akt activation and increased expression of antioxidant enzymes.

Conclusion
==========

Our results show that SDSS, a new synthetic H~2~S-releasing DSS derivative, protected MC3T3-E1 osteoblasts against oxidative-stress-induced cell injury, apoptosis, and arrest of differentiation. This is mediated by its antioxidant effect through inhibition of MAPKs and activation of PI3K/ Akt pathways. Our data imply that SDSS has the potential to be developed as a drug to treat osteoporosis. However, long-term pharmacological and toxicological studies in animals are necessary before any conclusion can be made.
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3-MST

:   3-mercaptopyruvate sulfurtransferase

ADT-OH

:   5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione

Ac-DSS

:   α, 3, 4-tris (acetyloxy)-benzenepropanoic acid

CBS

:   Cystathionine-β-synthase

CSE

:   cystathionine γ-lyase DSS

Danshensu

:   H~2~DCFDA, Dichlorodihydrofluorescein diacetate

rMSCs

:   rat bone marrow stromal cells

SDSS, α-3

:   4-tris (acetyloxy)-benzenepropanoic acid 4-(3-thioxo-3H-1, 2-dithiol-5-yl) phenyl ester.
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